Reported Q: Q4 2024 Rev YoY: -1.3% EPS YoY: -276.7% Move: -2.67%
Azenta Inc
0HQ1.L
$24.80 -2.67%
Exchange LSE Sector Healthcare Industry Medical Instruments Supplies
Q4 2024
Published: Nov 27, 2024

Company Status Snapshot

Fast view of the latest quarter outcome for 0HQ1.L

Reported

Report Date

Nov 27, 2024

Quarter Q4 2024

Revenue

170.06M

YoY: -1.3%

EPS

-0.10

YoY: -276.7%

Market Move

-2.67%

Previous quarter: N/A

Follow this company to get upcoming quarter alerts automatically.

Earnings Highlights

  • Revenue of $170.06M down 1.3% year-over-year
  • EPS of $-0.10 decreased by 276.7% from previous year
  • Gross margin of 40.8%
  • Net income of -4.98M
  • "Transcript data not provided." - N/A
0HQ1.L
Company 0HQ1.L

Executive Summary

Azenta Inc reported a modest revenue decline in Q4 2024, with revenue of $170.1 million, down ~1.3% year over year and ~1.6% quarter over quarter. Gross profit totaled $69.4 million for a gross margin of about 40.8%, indicating stable product mix despite topline pressure. The company delivered EBITDA of $13.4 million but posted an operating loss of $12.3 million, underscoring the ongoing impact of operating expenses on near-term profitability. Net income was negative at $4.98 million, with an EPS of -$0.10. On the liquidity and cash-flow front, Azenta generated operating cash flow of $13.7 million and free cash flow of $1.66 million, while ending the period with a robust liquidity position: cash and equivalents of $310.9 million and total cash & short-term investments of $462.1 million. The company also reported a net cash position (net debt of -$252.1 million), a healthy current ratio of 4.07 and a sizable cash balance that supports ongoing R&D and growth initiatives.

A notable feature of the quarter was aggressive capital allocation toward share repurchases, with approximately $248.9 million of common stock repurchased, which pressures cash on the balance sheet but can be accretive to per-share metrics over time. While the quarterly profitability story remains uneven (net margin at -2.93%), the year-over-year improvement in operating income (+26.1% YoY) indicates some operating leverage returning as the cost structure evolves.

Management commentary for QQ4 2024 is not provided in the supplied transcript data, so direct quotes or thematic takeaways from an earnings call cannot be cited here. The forward-looking guidance from management is not present in the provided material; investors should monitor quarterly cadence for margin expansion signals, and any commentary on services mix, informatics expansion, and international growth to gauge the trajectory toward sustained profitability.

Key Performance Indicators

Revenue
Decreasing
170.06M
QoQ: -1.59% | YoY: -1.33%
Gross Profit
Increasing
69.41M
40.82% margin
QoQ: 0.52% | YoY: 2.03%
Operating Income
Increasing
-12.29M
QoQ: -22.50% | YoY: 26.08%
Net Income
Decreasing
-4.98M
QoQ: 24.28% | YoY: -247.67%
EPS
Decreasing
-0.10
QoQ: 16.67% | YoY: -276.68%

Revenue Trend

Margin Analysis

Historical Earnings Comparison

PeriodRevenue ($M)EPS ($)YoY GrowthReport
Q4 2025 159.19 1.02 -6.4% View
Q3 2025 143.94 -1.15 -16.7% View
Q2 2025 143.42 -0.88 -9.9% View
Q1 2025 147.51 -0.29 -4.4% View
Q4 2024 170.06 -0.10 -1.3% View